tiprankstipranks
RenovoRx Shareholders Unanimously Elect Board Directors
Company Announcements

RenovoRx Shareholders Unanimously Elect Board Directors

Don't Miss Our Christmas Offers:

RenovoRx (RNXT) just unveiled an announcement.

At the 2024 annual meeting, the Company successfully elected six directors to a one-year term with over 10 million shares voting in favor and none against, showcasing solid stockholder support. The quorum was met with over 10 million shares represented, and the election of directors was the sole agenda item. Each nominee received a strong endorsement, indicating a unified trust in their leadership for the upcoming year.

For a thorough assessment of RNXT stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyRenovoRx announces SCRI Oncology partners enrolling patients for trial
TheFlyRenovoRx receives first purchase orders for FDA-cleared RenovoCath
TheFlyRenovoRx announces NHCI is enrolling patients for Phase III TIGeR-PaC trial
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App